Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries

Journal of Endotoxin Research

Volumn 13, Issue 5, 2007, Pages 297-304

  Alipour, Misagh ^a   Omri, Abdelwahab ^a   Smith, Milton G ^b   Suntres, Zacharias E ^c  

^a LAURENTIAN UNIVERSITY   (Canada)

^b Amaox Ltd   (United States)

^c LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Inflammation; Lipopolysaccharide; Liposomes; Liver; N Acetylcysteine; Oxidative stress

Indexed keywords

4 HYDROXYALKENAL; ACETYLCYSTEINE; ACETYLCYSTEINE LIPID COMPLEX; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; DIPALMITOYLPHOSPHATIDYLCHOLINE; MALONALDEHYDE; MUCOLYTIC AGENT; MYELOPEROXIDASE; OXOACID; SODIUM CHLORIDE; THIOL DERIVATIVE; TOSYLCHLORAMIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; IN VIVO STUDY; INFLAMMATION; LIPID PEROXIDATION; LIPOSOMAL DELIVERY; LIVER HOMOGENATE; LIVER INJURY; LIVER LEVEL; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHLORAMINES; DISEASE MODELS, ANIMAL; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; LYSINE; MALE; ORGAN SIZE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; ESCHERICHIA COLI; NEGIBACTERIA; RATTUS;

EID: 35848931018     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/0968051907085062     Document Type: Article

References (59)

1. Sakaguchi S., Furusawa S. Oxidative stress and septic shock: Metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 2006; 47: 167-177.
2. Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 2007; 22: 63-72.
3. Jirillo E., Caccavo D., Magrone T. et al. The role of the liver in the response to LPS: Experimental and clinical findings. J Endotoxin Res 2002; 8: 319-327.
4. Moran AP Lipopolysaccharide in bacterial chronic infection: Insights from Helicobacter pylori lipopolysaccharide and lipid A. Int J Med Microbiol 2007; 297: 307-319.
5. Hodgson JC Endotoxin and mammalian host responses during experimental disease. J Comp Pathol 2006; 135: 157-175.
6. Hsu BG, Lee RP, Yang FL, Harn HJ, Chen HI Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci 2006; 79: 2010-2016.
7. Roberts RA, Ganey PE, Ju C., Kamendulis LM, Rusyn I., Klaunig JE Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 2007; 96: 2-15.
8. Kaur G., Tirkey N., Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology 2006; 226: 152-160.
9. Li G., Liu Y., Tzeng NS et al. Protective effect of dextromethorphan against endotoxic shock in mice. Biochem Pharmacol 2005; 69: 233-240.
10. Karihtala P., Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis 2007; 115: 81-103.
11. Thakur V., Pritchard MT, McMullen MR, Wang Q., Nagy LE Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: Role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006; 79: 1348-1356.
12. Tukov FF, Maddox JF, Amacher DE, Bobrowski WF, Roth RA, Ganey PE Modeling inflammation-drug interactions in vitro: A rat Kupffer cell-hepatocyte coculture system. Toxicol In Vitro 2006; 20: 1488-1499.
13. Cerecetto H., Lopez GV Antioxidants derived from vitamin E: An overview. Mini Rev Med Chem 2007; 7: 315-338.
14. Mishra V. Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 2007; 53: 199-209.
15. Victor VM, Rocha M., Esplugues JV, De la Fuente M. Role of free radicals in sepsis: Antioxidant therapy Curr Pharm Des 2005; 11: 3141-3158.
16. Fan J., Shek PN, Suntres ZE, Li YH, Oreopoulos GD, Rotstein OD Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 2000; 128: 332-338.
17. Fang JY, Hwang TL, Huang YL, Fang CL Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006; 310: 131-138.
18. Gortzi O., Lalas S., Chinou I., Tsaknis J. Reevaluation of antimicrobial and antioxidant activity of Thymus spp. extracts before and after encapsulation in liposomes. J Food Prot 2006; 69: 2998-3005.
19. Padamwar MN, Pokharkar VB Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. Int J Pharm 2006; 320: 37-44.
20. Sarkar S., Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Ageing Dev 2006; 127: 391-397.
21. Suntres ZE Role of antioxidants in paraquat toxicity. Toxicology 2002; 180: 65-77.
22. Wasserman V., Kizelsztein P., Garbuzenko O. et al. The antioxidant tempamine: In vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release. Langmuir 2007; 23: 1937-1947.
23. Allison SD Liposomal drug delivery. J Infus Nurs 2007; 30: 89-95; quiz 120.
24. Suntres ZE, Omri A. The role of liposomal antioxidants in oxidative stress. Berlin: Springer, 2006.
25. Adrian JE, Kamps JA, Poelstra K., Scherphof GL, Meijer DK, Kaneda Y. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes. J Drug Target 2007; 15: 75-82.
26. Sato A., Takagi M., Shimamoto A., Kawakami S., Hashida M. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 2007; 28: 1434-1442.
27. Toklu HZ, Sehirli AO, Velioglu-Ogunc A., Cetinel S., Sener G. Acetaminophen-induced toxicity is prevented by beta-D-glucan treatment in mice. Eur J Pharmacol 2006; 543: 133-140.
28. Tsai CL, Chang WT, Weng TI, Fang CC, Walson PD A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ther 2005; 27: 336-341.
29. Sadowska AM, Manuel Ykb, De Backer WA Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: Discordant in vitro and in vivo dose-effects: A review. Pulm Pharmacol Ther 2007; 20: 9-22.
30. Mulier B., Rahman I., Watchorn T., Donaldson K., MacNee W, Jeffery PK. Hydrogen peroxide-induced epithelial injury: The protective role of intracellular nonprotein thiols (NPSH). Eur Respir J 1998; 11: 384-391.
31. Nagata K., Iwasaki Y., Yamada T. et al. Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med 2007; 101: 800-807.
32. Tsikas D., Sandmann J., Ikic M., Fauler J., Stichtenoth DO, Frolich JC Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J Chromatogr B Biomed Sci Appl 1998; 708: 55-60.
33. Li YQ, Zhang ZX, Xu YJ et al. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms. Acta Pharmacol Sin 2006; 27: 339-346.
34. Sury MD, Frese-Schaper M., Muhlemann MK et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med 2006; 41: 1372-1383.
35. Suntres ZE, Lui EM Biochemical mechanism of metallothionein- carbon tetrachloride interaction in vitro. Biochem Pharmacol 1990; 39: 833-840.
36. Gad SC, Weil CS Statistics for toxicoligists. New York: Raven, 1994.
37. Suntres ZE Prophylaxis against lipopolysaccharide-induced liver injuries by lipoic acid in rats. Pharmacol Res 2003; 48: 585-591.
38. Uchida K. Future of toxicology - lipid peroxidation in the future: From biomarker to etiology. Chem Res Toxicol 2007; 20: 3-5.
39. Glantzounis GK, Yang W., Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des 2006; 12: 2891-2901.
40. Jurczuk M., Moniuszko-Jakoniuk J., Brzoska MM Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology 2006; 219: 11-21.
41. Patsoukis N., Georgiou CD Determination of the thiol redox state of organisms: New oxidative stress indicators. Anal Bioanal Chem 2004; 378: 1783-1792.
42. Atis S., Nayci A., Ozge A., Comelekoglu U., Gunes S., Bagdatoglu O. N-Acetylcysteine protects the rats against phrenic nerve dysfunction in sepsis. Shock 2006; 25: 30-35.
43. Caglikulekci M., Dirlik M., Pata C. et al. Effect of N-acetylcysteine on blood and tissue lipid peroxidation in lipopolysaccharide-induced obstructive jaundice. J Invest Surg 2006; 19: 175-184.
44. Hsu BG, Yang FL, Lee RP, Peng TC, Harn HJ, Chen HI N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. J Biomed Sci 2004; 11: 152-162.
45. Smyrniotis V., Arkadopoulos N., Kostopanagiotou G. et al. Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. J Surg Res 2005; 129: 31-37.
46. Fishbane S., Durham JH, Marzo K., Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251-260.
47. Gillissen A., Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92: 609-623.
48. Caglikulekci M., Pata C., Apa DD et al. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacol Res 2004; 49: 227-238.
49. Chan EL, Murphy JT Reactive oxygen species mediate endotoxin-induced human dermal endothelial NF-kappaB activation. J Surg Res 2003; 111: 120-126.
50. Lappas M., Permezel M., Rice GE N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003; 88: 1723-1729.
51. Zafarullah M., Li WQ, Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60: 6-20.
52. Iseri SO, Sener G., Saglam B., Gedik N., Ercan F., Yegen BC Oxytocin protects against sepsis-induced multiple organ damage: Role of neutrophils. J Surg Res 2005; 126: 73-81.
53. Stief TW The physiology and pharmacology of singlet oxygen. Med Hypotheses 2003; 60: 567-572.
54. Vrba J., Modriansky M. Oxidative burst of Kupffer cells: Target for liver injury treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146: 15-20.
55. Lindner JR, Kahn ML, Coughlin SR et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 2000; 165: 6504-6510.
56. Wiedermann FJ, Mayr AJ, Hobisch-Hagen P., Fuchs D., Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003; 23: 729-736.
57. Suntres ZE, Shek PN Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. Biochem Pharmacol 2000; 59: 1155-1161.
58. Ohbayashi H. Novel neutrophil elastase inhibitors as a treatment for neutrophil-predominant inflammatory lung diseases IDrugs 2002; 5: 910-923.
59. Wakayama F., Fukuda I., Suzuki Y., Kondo N. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007; 83: 153-160.